Kobayashi Tsuyoshi, Nakatani Yoshihito, Tanioka Toshihiro, Tsujimoto Masafumi, Nakajo Shigeo, Nakaya Kazuyasu, Murakami Makoto, Kudo Ichiro
Department of Health Chemistry, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Biochem J. 2004 Jul 1;381(Pt 1):59-69. doi: 10.1042/BJ20040118.
cPGES [cytosolic PG (prostaglandin) E synthase] is constitutively expressed in various cells and can regulate COX (cyclo-oxygenase)-1-dependent immediate PGE2 generation. In the present study, we found that cPGES underwent serine phosphorylation, which was accelerated transiently after cell activation. Several lines of evidence suggest that a cPGES-activating protein kinase is CK-II (casein kinase II). Recombinant cPGES was phosphorylated directly by and associated with CK-II in vitro, resulting in marked reduction of the K m for the substrate PGH2. In activated cells, cPGES phosphorylation occurred in parallel with increased cPGES enzymic activity and PGE2 production from exogenous and endogenous arachidonic acid, and these processes were facilitated by Hsp90 (heat-shock protein 90), a molecular chaperone that formed a tertiary complex with cPGES and CK-II. Treatment of cells with inhibitors of CK-II and Hsp90 and with a dominant-negative CK-II attenuated the formation of the cPGES-CK-II-Hsp90 complex and attendant cPGES phosphorylation and activation. Mutations of either of two predicted CK-II phosphorylation sites on cPGES (Ser113 and Ser118) abrogated its phosphorylation and activation both in vitro and in vivo. Moreover, the CK-II-Hsp90-mediated activation of cPGES was ameliorated by the p38 mitogen-activated protein kinase inhibitor SB20358 or by the anti-inflammatory glucocorticoid dexamethasone. Taken together, the results of the present study have provided the first evidence that the cellular function of this eicosanoid-biosynthetic enzyme is under the control of a molecular chaperone and its client protein kinase.
胞质型前列腺素E合酶(cPGES)在多种细胞中组成性表达,可调节环氧化酶(COX)-1依赖性的即时前列腺素E2生成。在本研究中,我们发现cPGES发生丝氨酸磷酸化,细胞激活后这种磷酸化会短暂加速。多项证据表明,一种激活cPGES的蛋白激酶是酪蛋白激酶II(CK-II)。重组cPGES在体外可被CK-II直接磷酸化并与之结合,导致其对底物前列腺素H2的米氏常数显著降低。在激活的细胞中,cPGES磷酸化与cPGES酶活性增加以及外源性和内源性花生四烯酸生成前列腺素E2同时发生,这些过程受到热休克蛋白90(Hsp90)的促进,Hsp90是一种分子伴侣,与cPGES和CK-II形成三元复合物。用CK-II和Hsp90抑制剂以及显性负性CK-II处理细胞,可减弱cPGES-CK-II-Hsp90复合物的形成以及随之而来的cPGES磷酸化和激活。cPGES上两个预测的CK-II磷酸化位点(Ser113和Ser118)中的任何一个发生突变,都会在体外和体内消除其磷酸化和激活。此外,p38丝裂原活化蛋白激酶抑制剂SB20358或抗炎糖皮质激素地塞米松可改善CK-II-Hsp90介导的cPGES激活。综上所述,本研究结果首次证明,这种类花生酸生物合成酶的细胞功能受分子伴侣及其客户蛋白激酶的调控。